Hsu-Ping Kuo

2.3k total citations
12 papers, 1.1k citations indexed

About

Hsu-Ping Kuo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hsu-Ping Kuo has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Hsu-Ping Kuo's work include Cell death mechanisms and regulation (3 papers), Signaling Pathways in Disease (3 papers) and NF-κB Signaling Pathways (3 papers). Hsu-Ping Kuo is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Signaling Pathways in Disease (3 papers) and NF-κB Signaling Pathways (3 papers). Hsu-Ping Kuo collaborates with scholars based in United States, Taiwan and China. Hsu-Ping Kuo's co-authors include Mien‐Chie Hung, Dung‐Fang Lee, Long‐Yuan Li, Chien‐Chen Lai, Weiya Xia, Chun‐Te Chen, Chao‐Kai Chou, Qingqing Ding, Mo Liu and Jung-Mao Hsu and has published in prestigious journals such as Molecular Cell, Nature Cell Biology and Cancer Cell.

In The Last Decade

Hsu-Ping Kuo

12 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsu-Ping Kuo United States 12 892 274 187 167 99 12 1.1k
Toshiyuki Tsunoda Japan 23 843 0.9× 328 1.2× 333 1.8× 149 0.9× 88 0.9× 77 1.3k
Carmen Aanei France 12 484 0.5× 219 0.8× 205 1.1× 151 0.9× 61 0.6× 22 979
Wen-Chun Hung Taiwan 25 809 0.9× 366 1.3× 369 2.0× 119 0.7× 62 0.6× 30 1.3k
Yong-Sam Jung United States 17 834 0.9× 417 1.5× 250 1.3× 107 0.6× 66 0.7× 23 1.1k
Marta Martínez Spain 16 717 0.8× 262 1.0× 299 1.6× 177 1.1× 93 0.9× 28 1.2k
Ashraful Islam United States 7 939 1.1× 316 1.2× 301 1.6× 127 0.8× 43 0.4× 12 1.2k
Subbulakshmi Virudachalam United States 18 705 0.8× 381 1.4× 274 1.5× 98 0.6× 109 1.1× 21 1.2k
Zhu Yuan China 24 1.0k 1.1× 394 1.4× 274 1.5× 180 1.1× 87 0.9× 68 1.4k
Fuxiang Zhou China 24 862 1.0× 223 0.8× 345 1.8× 93 0.6× 86 0.9× 78 1.2k
Susumu Rokudai Japan 16 742 0.8× 386 1.4× 177 0.9× 166 1.0× 36 0.4× 29 1.0k

Countries citing papers authored by Hsu-Ping Kuo

Since Specialization
Citations

This map shows the geographic impact of Hsu-Ping Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsu-Ping Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsu-Ping Kuo more than expected).

Fields of papers citing papers by Hsu-Ping Kuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsu-Ping Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsu-Ping Kuo. The network helps show where Hsu-Ping Kuo may publish in the future.

Co-authorship network of co-authors of Hsu-Ping Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Hsu-Ping Kuo. A scholar is included among the top collaborators of Hsu-Ping Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsu-Ping Kuo. Hsu-Ping Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kuo, Hsu-Ping, Zhong Wang, Dung‐Fang Lee, et al.. (2013). Epigenetic Roles of MLL Oncoproteins Are Dependent on NF-κB. Cancer Cell. 24(4). 423–437. 63 indexed citations
2.
Chen, Chun‐Te, Yi Du, Hirohito Yamaguchi, et al.. (2012). Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer. Molecular Cancer Therapeutics. 11(10). 2212–2221. 21 indexed citations
3.
Hsu, Jung-Mao, Chun‐Te Chen, Chao‐Kai Chou, et al.. (2011). Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation. Nature Cell Biology. 13(2). 174–181. 195 indexed citations
4.
Liu, Mo, Dung‐Fang Lee, Chun‐Te Chen, et al.. (2011). IKKα Activation of NOTCH Links Tumorigenesis via FOXA2 Suppression. Molecular Cell. 45(2). 171–184. 76 indexed citations
5.
Kuo, Hsu-Ping, Dung‐Fang Lee, Weiya Xia, Yongkun Wei, & Mien‐Chie Hung. (2009). TNFα induces HIF-1α expression through activation of IKKβ. Biochemical and Biophysical Research Communications. 389(4). 640–644. 25 indexed citations
6.
Lee, Dung‐Fang, Hsu-Ping Kuo, Mo Liu, et al.. (2009). KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ. Molecular Cell. 36(1). 131–140. 333 indexed citations
7.
Kuo, Hsu-Ping, Dung‐Fang Lee, Weiya Xia, et al.. (2009). Phosphorylation of ARD1 by IKKβ contributes to its destabilization and degradation. Biochemical and Biophysical Research Communications. 389(1). 156–161. 15 indexed citations
8.
Yen, Chia-Jui, Julie Izzo, Dung‐Fang Lee, et al.. (2008). Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma. Cancer Research. 68(8). 2632–2640. 49 indexed citations
9.
Ding, Qingqing, Longfei Huo, Jer-Yen Yang, et al.. (2008). Down-regulation of Myeloid Cell Leukemia-1 through Inhibiting Erk/Pin 1 Pathway by Sorafenib Facilitates Chemosensitization in Breast Cancer. Cancer Research. 68(15). 6109–6117. 163 indexed citations
10.
Xie, Xiaoming, Weiya Xia, Zhongkui Li, et al.. (2007). Targeted Expression of BikDD Eradicates Pancreatic Tumors in Noninvasive Imaging Models. Cancer Cell. 12(1). 52–65. 61 indexed citations
11.
Chen, Jin‐Shing, Lei Shen, Hsu-Ping Kuo, et al.. (2004). Cancer-specific activation of the survivin promoter and its potential use in gene therapy. Cancer Gene Therapy. 11(11). 740–747. 97 indexed citations
12.
Li, Yan M., Yong Wen, Binhua P. Zhou, et al.. (2003). Enhancement of Bik antitumor effect by Bik mutants.. PubMed. 63(22). 7630–3. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026